Umeclidinium

Overview

Umeclidinium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1187833).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Umeclidinium expires 18 Dec 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol

Canonical SMILES

C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5

InChIKey

FVTWTVQXNAJTQP-UHFFFAOYSA-N